AI-Generated Content — This profile was created using AI and publicly available sources. While we strive for accuracy, details may contain errors or be outdated. Quotes may be paraphrased or taken out of context. Achievements and figures are based on public reporting and may not be precise. This profile does not imply endorsement by the individual featured. Not financial advice.
Phillip Frost
United States
About Phillip Frost
Phillip Frost, M.D., is an American physician, entrepreneur, and one of the most distinctive figures in modern pharmaceutical investing. Born in Philadelphia in 1936, he trained as a dermatologist at the Albert Einstein College of Medicine and built his career in Miami, where he has been a fixture of the city's medical, scientific, and philanthropic life for more than half a century. He is married to Patricia Frost, his partner of decades, with whom he has shared an extraordinary record of giving.
Frost's business career rests on three pillars. In 1972 he co-founded Key Pharmaceuticals, where he commercialized the Nicoderm transdermal nicotine patch and built the company into an attractive specialty pharma player. Schering-Plough acquired Key in 1986 for approximately $835 million, establishing Frost as a serious operator. He then built IVAX Corporation into one of the world's largest generic-drug companies, ultimately selling it to Teva Pharmaceutical Industries in 2006 for approximately $7.4 billion. Since 2007 he has served as Chairman and CEO of OPKO Health (NASDAQ: OPK), a diagnostics and pharmaceutical company where he is by far the largest insider holder and is famous on Wall Street for his unusually consistent Form 4 insider buying — sometimes filing purchases on a near-weekly cadence for years at a time.
Frost's career has not been without controversy. In 2018 the SEC charged him in connection with an alleged pump-and-dump scheme involving small-cap stocks (BIOZ, MGT, MBOT). He settled in 2019 without admitting wrongdoing, paid a roughly $5.5 million penalty, and accepted a penny-stock officer/director bar. He has continued to lead OPKO and to file insider buys in the years since. Beyond business, Frost is one of South Florida's most active philanthropists — the Frost Museum of Science (Miami), the Frost School of Music (University of Miami), and the Frost Art Museum (FIU) all bear his and Patricia's name, alongside major gifts to Albert Einstein College of Medicine. He is also a serious art collector. The throughline across all of it is persistence: he keeps showing up, keeps buying, keeps building.
Key Achievements
Built and Sold Key Pharmaceuticals
Co-founded Key Pharmaceuticals in 1972 and developed the Nicoderm transdermal nicotine patch into a category-defining product. Sold the company to Schering-Plough in 1986 for approximately $835 million.
Built IVAX into a Generics Powerhouse
Transformed IVAX Corporation into one of the world's largest generic pharmaceutical companies through decades of acquisitions and operational discipline. Sold IVAX to Teva Pharmaceutical Industries in 2006 for approximately $7.4 billion.
Founder, Chairman & CEO of OPKO Health
Has led OPKO Health (NASDAQ: OPK) since 2007, building a diversified diagnostics and pharmaceutical company. Remains the largest insider holder by a wide margin.
Most Consistent Insider Buyer on Wall Street
Famous for filing SEC Form 4 insider purchases of OPKO stock with unusual consistency over many years, often near-weekly during long stretches. The pattern has become a case study in conviction and signaling.
Defining Philanthropist of South Florida
With Patricia Frost, has been the named donor behind the Frost Museum of Science (Miami), the Frost School of Music (University of Miami), and the Frost Art Museum (FIU), plus major gifts to Albert Einstein College of Medicine.
Notable Quotes
“If I believe in a company, I want to own as much of it as I can. (paraphrased)”
— Phillip Frost
“Persistence is the most underrated investing skill. (paraphrased)”
— Phillip Frost
“I bet on people I know and businesses I understand. (paraphrased)”
— Phillip Frost
“Medicine taught me to read the data, not the headlines. (paraphrased)”
— Phillip Frost
“If a stock is cheap and the story is right, you keep buying. (paraphrased)”
— Phillip Frost
Key Decisions
Earned his M.D. from Albert Einstein College of Medicine. Trained as a dermatologist, which would later anchor his philanthropic ties to Einstein.
Co-founded Key Pharmaceuticals — his first serious operating bet on a specialty-pharma platform.
Sold Key Pharmaceuticals to Schering-Plough for approximately $835 million; the Nicoderm transdermal nicotine patch was the crown jewel of the deal.
Took control of IVAX Corporation and began converting it into a global generics platform through serial acquisitions.
Sold IVAX Corporation to Teva Pharmaceutical Industries for approximately $7.4 billion — one of the largest pharmaceutical deals of its era.
Became Chairman and CEO of OPKO Health and began the multi-decade pattern of insider Form 4 buying that would define his public profile.
Closed OPKO's acquisition of PROLOR Biotech, expanding into long-acting therapeutic proteins.
Closed OPKO's acquisition of Bio-Reference Laboratories, transforming OPKO into a major diagnostics company; integrated the 4Kscore prostate cancer test into its lineup.
SEC charged Frost in connection with an alleged pump-and-dump scheme involving certain small-cap stocks (BIOZ, MGT, MBOT).
Settled the SEC matter without admitting wrongdoing, paid a penalty of approximately $5.5 million, and accepted a penny-stock officer/director bar. Continued as Chairman and CEO of OPKO.
OPKO and BioReference were among the largest U.S. processors of COVID-19 PCR tests during the pandemic.
Continued filing OPKO Form 4 insider purchases — the multi-decade pattern of buying his own company's stock remained intact.
Early Life
Born in Philadelphia in 1936. Studied at the University of Pennsylvania and earned his M.D. from the Albert Einstein College of Medicine in 1961. Trained as a dermatologist and practiced medicine before pivoting to pharmaceutical entrepreneurship in the early 1970s. Settled in Miami, where he has lived and worked for the bulk of his career.
Companies & Ventures
Key Pharmaceuticals
$835M (1986 sale)Co-founder · Est. 1972
Specialty pharmaceutical company built around novel drug-delivery technology. Crown jewel was the Nicoderm transdermal nicotine patch. Acquired by Schering-Plough in 1986 for approximately $835 million.
IVAX Corporation
$7.4B (2006 sale)Chairman & CEO · Est. 1987
Built into one of the world's largest generic pharmaceutical companies through serial acquisitions and operational integration. Acquired by Teva Pharmaceutical Industries in 2006 for approximately $7.4 billion.
OPKO Health
Chairman & CEO · Est. 2007
Diversified diagnostics and pharmaceutical company. Owns BioReference Laboratories (a major U.S. clinical lab) and a portfolio of pharmaceuticals including Rayaldee. Frost is by far the largest insider holder and the most consistent insider buyer on Wall Street.
Investment Principles
Insider Buying as a Personal Philosophy
Frost has spent decades publicly buying his own companies' stock through SEC Form 4 filings. The signal is unmistakable: if you believe, you keep buying — through every cycle, every short report, every regulatory event.
Vertical Integration in Pharma
Key Pharmaceuticals, IVAX, and OPKO all reflect a preference for owning the full stack — drug development, manufacturing, distribution, and (with BioReference) diagnostics. Control of the platform compounds.
Persistence Over Brilliance
Frost's record is built less on individual brilliant trades than on showing up, decade after decade, in the same names. Persistence as an investing edge is rare and underpriced.
Domain Expertise Compounds
A trained dermatologist, Frost has stayed within healthcare and life sciences for his entire career. Deep, narrow domain knowledge, applied across forty years, is its own kind of moat.
Long Holding Periods, Quiet Operator
Frost is not a Belfort and not a Buffett-sized public figure. He is a quiet operator who holds for years, sometimes decades, and lets compounding do the work.
Life Lessons & Insights
Show Up Every Tuesday
The most distinctive thing about Phillip Frost as an investor is not any single trade. It is that he keeps filing Form 4 insider buys, year after year, through every market environment. Consistency is its own talent.
Stay in Your Lane
Frost has never ventured far from healthcare. A dermatologist who became a pharmaceutical entrepreneur and a diagnostics builder — a single coherent thread across a sixty-year career.
Setbacks Are Not the Story
The 2018 SEC matter was real and was settled in 2019 without admission of wrongdoing. Frost continued to lead OPKO and continued to buy its stock. Refusing to disappear is itself a strategy.
Give While You Live
The Frosts have been among the most active philanthropists in South Florida. Their names are on a science museum, a music school, an art museum, and a medical school — all completed during their lifetimes, not bequeathed.
Marriage as Infrastructure
Patricia Frost is not a footnote in Phillip's biography. The 'Frost' on every museum, school, and gallery is theirs together. Decades of stable partnership is a form of compounding most billionaires never achieve.
Philanthropy
Phillip and Patricia Frost are among the defining philanthropists of South Florida. Major named gifts include the Phillip and Patricia Frost Museum of Science (Miami), the Phillip and Patricia Frost School of Music at the University of Miami, and the Patricia & Phillip Frost Art Museum at Florida International University. They have also been substantial donors to the Albert Einstein College of Medicine, where Phillip earned his M.D., and to numerous other Miami-area cultural and medical institutions.
Deep Dives
Go deeper into what makes Phillip Frost exceptional.
Enjoyed this? Get more like it.
Glen's Musings — AI, investing, and building things. Occasional. Free.
Explore More
See how Glen Bradford applies these principles to his own investing. Long Fannie Mae & Freddie Mac junior preferred — and not going anywhere.